Sign in
CompletedNo phase

Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain

Key facts

Who runs it
Paradigm Biopharmaceuticals Ltd.
Where
Chicago, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Status
Completed
People taking part
133 people enrolled
Started
24 Jun 2023
Ended
24 Dec 2024
Type of study
Observational, 2 groups
Treatments tested
  • Pentosan Polysulphate Sodium
  • Placebo (Sodium Chloride Injection, 0.9%)
Record updated
22 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (3)Hide the full registry criteria

Who can take part

  • Participants who completed Day 168 of Study PARA_OA_002 (ie, did not discontinue/withdrew prematurely from the parent study)
  • Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol

Who cannot take part

  • An employee of the Sponsor, clinical research organisations or research site personnel directly affiliated with this study or their immediate family members defined as a spouse, parent, sibling, or child, whether biological or legally adopted

Where in United States

Also in 1 other country, 1 site

  • Northwestern University Feinberg School of MedicineChicago, United States

About the trial

What the trial wants to find out

The purpose of this study is to measure the duration of treatment effect with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with placebo in adult participants with knee osteoarthritis (OA) pain. The study duration will be up to 34 weeks.

Read full original descriptionShow less

Participants who completed pDay 162 of Study PARA_OA_002 (i.e. did not discontinue/withdraw prematurely from the parent study) will be invited to participate.

The 2 groups in the trial

  • Pentosan Polysulfate Sodium

    Pentosan Polysulfate Sodium (PPS) at Dose and frequency selected in Stage 1 of Parent Study for 6 weeks

    Treatment: Pentosan Polysulphate Sodium

  • Placebo

    Placebo for 6 weeks

    Treatment: Placebo (Sodium Chloride Injection, 0.9%)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Observational Follow-up Study to Investigate the Duration of Treatment Effect With Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain
Record updated
22 July 2025